Preparations are gathering pace for the United Nations General Assembly Special Session (UNGASS) on drugs, to be held on the 19th to 21st April 2016 in New York. Following several months of discussion on procedural elements, attention is now focused on negotiating the content of the "short, substantive, concise and action-orientated outcome document comprising a set of operational recommendations" to be approved by the General Assembly next April. At the CND intersessional meeting on 12th June, countries and regional groups were invited to submit their first ideas for what could be included in this Outcome Document, by a deadline of 11th September.
On June 25, 2015, the United States issued a formal request to the Mexican government for the extradition of Joaquín Guzmán Loera, known as El Chapo, who was being held at Mexico’s highest security prison. On July 11, less than three weeks later, Guzmán Loera released himself from the supposedly impregnable prison in President Enrique Peña Nieto’s home state, by means of a sixty-foot-deep tunnel that had apparently been dug from a half-built house a mile away, directly into the shower of his prison cell. (See also: Chapo saga highlights Mexico's convoluted extradition policy)
Drug policy reform is currently higher on the international agenda than it has been in recent memory. With a United Nations General Assembly Special Session (UNGASS) on drugs set for 19-21 April 2016, the prominence of this issue will further increase. Significant legal and policy reforms at the national level have taken place in recent years that pose considerable challenges to the international legal framework for drug control, and beg important questions regarding states’ international legal obligations.
Establecido en 2009, el Centro Internacional de Derechos Humanos y Políticas de Drogas se dedica al desarrollo y promoción de investigación y enseñanza legal innovadora y de alta calidad en materia de políticas públicas sobre el control de drogas y su implementación, en acorde con los principios de derechos humanos internacionales....
The Global Drug Policy Observatory aims to promote evidence and human rights based drug policy through the comprehensive and rigorous reporting, monitoring and analysis of policy developments at national and international levels. Acting as a platform from which to reach out to and engage with broad and diverse audiences, the initiative aims to help improve the sophistication and horizons of the...
Italy took a first step toward legalization of pot, leading Europe in what would be a groundbreaking change. The Intergrupo Parlamentare Cannabis Legale, a cross-party committee, agreed on a provisional text to legalize the consumption, growing, production and sale of cannabis under certain conditions. The text was signed by 218 members of parliament, and not just by the usual suspects. The proposal would allow growing cannabis at home or as members of "cannabis clubs" where a maximum of 50 people could cultivate and then share the product, with a strict prohibition on selling to the general public. (See also: Bill would legalize marijuana)
Drug law reform continues developing in the right direction in several Latin American and Caribbean countries. In Jamaica, for example, a law legalizing the cultivation and consumption of ganja for medicinal, religious and research purposes came into force, as well as the decriminalisation of possession for personal use. Jamaica also spoke out at the UN Thematic Debate in New York. On May 7th, the minister addressed the UN High Level Thematic Debate on international drug policy, highlighting Jamaica’s perspectives on drug control policies and participating in a debate that encourages open and inclusive discussions. Amongst the outcomes Jamaica would like to see from UNGASS is “the establishment of an Expert Advisory Group to review the UN drug policy control architecture, its system-wide coherence, its treaty inconsistencies and its legal tension with cannabis regulations.”
Calling it an issue America can’t afford to ignore, President Barack Obama laid out an expansive vision for fixing the criminal justice system. “In far too many cases, the punishment simply doesn’t fit the crime,” Obama told a crowd of 3,300 in Philadelphia. Low-level drug dealers, for example, owe a debt to society, but not a life sentence or 20-year prison term, he said. The United States needed to reevaluate an “aspect of American life that remains particularly skewed by race and by wealth.” Working in Obama’s favor: tentative but optimistic signs of common ground between Republicans and Democrats. (See also: President Obama for the prisoners)
For decades, ketamine was only manufactured by pharmaceutical companies. Technically, it was too complicated to be made by amateur chemists. But in the past five years, that has changed. Chinese drug gangs have cracked the code, figuring out how to manufacture large batches of cheap ketamine. Drug traffickers don't bother to steal ketamine from legal sources anymore. Instead, they're making their own. It's largely a Chinese breakthrough.
Marijuana may not be the "gateway drug" some believe it to be, a new study contends. Instead, teens smoke pot for very specific reasons, and it is those reasons that appear to prompt their decision to try other drugs, researchers report. For example, kids who use marijuana because they are bored are more likely to also use cocaine, while kids using pot to achieve insight or understanding are more likely to try magic mushrooms, according to findings published recently in the American Journal of Drug and Alcohol Abuse.
Nuevos Enfoques en materia de Intervenciones y Políticas de Drogas
El proyecto NADPI tiene por objetivo reforzar la base científica de la formulación de políticas de drogas en Europa mejorando la base de conocimientos y el intercambio de mejores prácticas sobre una serie de dilemas normativos clave relacionados con la reducción de la demanda, la prevención y las estrategias de reducción de daños.
El proyecto Nuevos Enfoques en materia de Intervenciones y...
Traditional small ganja farmers in Jamaica, accustomed to clandestinely working their fields, will now have to adhere to strict regulations in order to supply research institutions that have been granted licences.
Australians should be able to buy a pure form of ecstasy from their local pharmacy to curtail the harm caused by contaminated blackmarket pills. Melbourne pharmacist Joshua Donelly and leading doctor Professor David Penington say many Australians taking the drug were probably swallowing contaminated versions that put them at greater risk of harm. In the Journal of Law and Medicine, Donelly said although no drug was completely risk-free, compared to other drugs MDMA caused "negligible" harm to users and people around them.